Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:460 (26 February), doi:10.1136/bmj.38378.607130.55 (published 31 January 2005)
Mark Woodhead, consultant1, Theo J M Verheij, professor of general practice2
1 Department of Respiratory Medicine, Manchester Royal Infirmary, Manchester M13 9WL, 2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100 3584 CG Utrecht, Netherlands
Correspondence to: M Woodhead
| The first 150 words of the full text of this article appear below. |
Few topics cause such fierce discussion among doctors as does the antimicrobial treatment of lower respiratory tract infections. The meta-analysis by Mills et al is a valuable contribution to these debates.1 Their study should reassure all health professionals who routinely manage non-severe community acquired pneumonia that therapy using oral
lactam antibiotics, macrolides, or fluoroquinolones is equally effective when judged by clinical cure and mortality. Although other relevant outcomes such as speed of response, subsequent relapse rates, and harmful antibiotic effects were not assessed, the findings and the different cost and side effect profile of these agents means that a
lactam antibiotic (with macrolides and tetracyclines as good alternatives in individuals who are hypersensitive to penicillin) should usually remain the preferred therapy for patients with non-severe community acquired pneumonia managed in the community or in hospital. This is supported by data from clinical practice (as opposed to clinical trials) in Sweden.2
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis
Read all Rapid Responses